Chronic Kidney Disease

21 competing products in clinical development for Chronic Kidney Disease.

Pipeline by Phase

Pre-clinical2

Phase 11

Phase 28

Phase 39

Approved1

Product	Company	Stage	Status	Hype
Roxadustat	Astellas Pharma	Phase 3	Recruiting	47
Empagliflozin + Matching placebo	Eli Lilly	Phase 3	Completed	40
ASP1585	Astellas Pharma	Phase 3	Completed	40
roxadustat	Astellas Pharma	Phase 3	Completed	40
ASP1585 + placebo	Astellas Pharma	Phase 3	Completed	40
ASP1585 + Sevelamer hydrochloride	Astellas Pharma	Phase 3	Completed	40
roxadustat + DA	Astellas Pharma	Phase 3	Completed	40
ASP1585	Astellas Pharma	Phase 3	Completed	40
ASP1585	Astellas Pharma	Phase 3	Completed	40
Telmisartan/Rosuvastatin 40/10mg + Telmisartan 40mg	Yuhan	Approved	UNKNOWN	39
LY2623091 + Eplerenone	Eli Lilly	Phase 2	Completed	35
ASP8232 + Placebo	Astellas Pharma	Phase 2	Completed	35
Roxadustat	Astellas Pharma	Phase 2	Completed	35
Roxadustat + Placebo	Astellas Pharma	Phase 2	Completed	35
Roxadustat	Astellas Pharma	Phase 2	Completed	35
RTA 402 + Placebo	Kyowa Kirin	Phase 2	Completed	35
SGLT2 inhibitor	Eli Lilly	Pre-clinical	Active	30
ASP3325	Astellas Pharma	Phase 1	Completed	29
RTA 402	Kyowa Kirin	Phase 2	Terminated	27
RTA 402	Kyowa Kirin	Phase 2	Terminated	27
Bixalomer	Astellas Pharma	Pre-clinical	Completed	26